AbbVie has decided against progressing a recommendation by the Pharmaceutical Benefits Advisory Committee for the listing of VENCLEXTA (venetoclax). …
Latest Video
New Stories
-
Is that consulting or informing?
November 19, 2018 - - Latest News -
RVA welcomes funding for rare disease framework
November 19, 2018 - - Latest News -
Allergan partners with Glaucoma Australia
November 19, 2018 - - Latest News -
R&D tax change driven by savings target
November 19, 2018 - - Latest News -
Government tables report response
November 19, 2018 - - Latest News -
Pharmaxis reports new positive results for LOXL2 program
November 16, 2018 - - Latest News -
Government extends CSO contracts and links outcome to SPA changes
November 16, 2018 - - Latest News